Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16917005 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone, Dexamethasone, Vincristine, Daunorubicin, PEG-L-asparaginase;   Drug: L-asparaginase, Methotrexate, Idarubicin, Etoposide, Cyclophosphamide, Cytarabine, Mercaptopurine

Indicates status has not been verified in more than two years